TransMedics Group (TMDX) Insider Trading & Ownership $106.79 -3.18 (-2.89%) Closing price 04:00 PM EasternExtended Trading$107.50 +0.71 (+0.66%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TransMedics Group (NASDAQ:TMDX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.00%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$12.15M Get TMDX Insider Trade Alerts Want to know when executives and insiders are buying or selling TransMedics Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TMDX Insider Buying and Selling by Quarter TransMedics Group Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/9/2025Anil P RanganathInsiderSell686$139.80$95,902.80 5/27/2025Edward M BasileDirectorSell5,000$126.45$632,250.00 5/23/2025David WeillDirectorSell732$123.88$90,680.16 5/9/2025Edward M BasileDirectorSell6,000$115.63$693,780.00 12/2/2024Tamer I KhayalInsiderSell1,084$86.40$93,657.60 11/5/2024Edward M BasileDirectorSell6,750$83.55$563,962.50 10/15/2024Waleed H HassaneinCEOSell8,625$132.71$1,144,623.75 10/1/2024Tamer I KhayalInsiderSell2,958$148.24$438,493.92 9/16/2024Waleed H HassaneinCEOSell8,625$153.42$1,323,247.50 8/27/2024Nicholas CorcoranInsiderSell10,000$176.02$1,760,200.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/8/2024James R TobinDirectorSell20,000$159.33$3,186,600.00 8/7/2024Anil P RanganathInsiderSell4,289$152.20$652,785.80 8/6/2024Edward M BasileDirectorSell6,750$149.96$1,012,230.00 8/1/2024Tamer I KhayalInsiderSell2,958$156.77$463,725.66 (Data available from 1/1/2013 forward) TMDX Insider Trading Activity - Frequently Asked Questions Who is on TransMedics Group's Insider Roster? The list of insiders at TransMedics Group includes Anil P Ranganath, David Weill, Edward M Basile, James R Tobin, John F Carey, Laura Damme, Miriam Provost, Nicholas Corcoran, Stephanie Lovell, Stephen Gordon, Tamer I Khayal, and Waleed H Hassanein. Learn more on insiders at TMDX. What percentage of TransMedics Group stock is owned by insiders? 7.00% of TransMedics Group stock is owned by insiders. Learn more on TMDX's insider holdings. Which TransMedics Group insiders have been buying company stock? The following insider purchased TMDX shares in the last 24 months: David Weill ($155,000.00). How much insider buying is happening at TransMedics Group? Insiders have purchased a total of 2,500 TMDX shares in the last 24 months for a total of $155,000.00 bought. Which TransMedics Group insiders have been selling company stock? The following insiders have sold TMDX shares in the last 24 months: Anil P Ranganath ($843,741.23), David Weill ($584,218.61), Edward M Basile ($4,450,711.02), James R Tobin ($8,111,402.85), Miriam Provost ($489,698.36), Nicholas Corcoran ($2,178,770.02), Stephen Gordon ($10,255,825.69), Tamer I Khayal ($12,183,663.44), and Waleed H Hassanein ($19,017,058.75). How much insider selling is happening at TransMedics Group? Insiders have sold a total of 529,065 TransMedics Group shares in the last 24 months for a total of $58,115,089.97 sold. TransMedics Group Key ExecutivesDr. Waleed H. Hassanein M.D. (Age 56)Founder, President, CEO & Director Compensation: $1.82MMr. Stephen Gordon (Age 56)CFO, Treasurer & Secretary Compensation: $909.62kMr. Nicholas Corcoran (Age 41)Senior Vice President of Supply Chain & Operations Compensation: $812.07kMr. Anil RanganathSenior VP, General Counsel & Corporate Secretary1 recent tradesDr. Tamer I. Khayal M.D. (Age 55)Chief Commercial Officer Compensation: $900.11kMr. Mark AndersonSenior Director of Technology DevelopmentMs. Susan GoodmanVice President of Human ResourcesMs. Miriam C. Provost Ph.D. (Age 63)Vice President of Global Regulatory Affairs Compensation: $535.93k More Insider Trading Tools from MarketBeat Related Companies Smith & Nephew SNATS Insider Selling Solventum Insider Selling Penumbra Insider Selling Glaukos Insider Selling Bausch + Lomb Insider Selling iRhythm Technologies Insider Selling Soleno Therapeutics Insider Selling Inspire Medical Systems Insider Selling Envista Insider Selling PROCEPT BioRobotics Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (NASDAQ:TMDX) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransMedics Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransMedics Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
